Search research articles
Contact Us
Filters
Showing results (191-200 of 284) with videos related to
Page
of 29
Sort By:
Clinical, Cosmetic and Investigational Dermatology
|
April 10, 2023
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study
Marina Talamonti, Filomena Russo, Giovanna Malara, et al.
Dermatology and Therapy
|
January 23, 2025
Real-Life Experience with Tildrakizumab in Plaque Psoriasis with Palmoplantar Involvement: A Multi-Center Retrospective Italian Study
Federico Diotallevi, Maria Esposito, Maria Concetta Fargnoli, et al.
Dermatology Practical & Conceptual
|
March 30, 2026
A Risk-Scoring Classifier for the Diagnosis and Management of Atypical Melanocytic Lesions of the Palms: the iDScore_palmar Model
Linda Tognetti, Sofia Lo Conte, Chiara Miracapillo, et al.
Dermatology Practical & Conceptual
|
November 14, 2025
GRINCH Index: Measuring Patient Satisfaction During Christmas Holiday Gift Programs
Giulio Gualdi, Laura Bigi, Clara De Simone, et al.
Psoriasis (Auckland, N.Z.)
|
September 22, 2025
Long-Term Real-World Effectiveness and Drug Survival of Guselkumab in Patients with Psoriasis: A 5-Year Retrospective Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
Expert Opinion on Biological Therapy
|
June 16, 2022
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year
Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini, et al.
The Journal of Investigative Dermatology
|
July 30, 2013
Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families
Xueying Liang, Ruth M Pfeiffer, Wen-Qing Li, et al.
Dermatology (Basel, Switzerland)
|
November 2, 2023
Molecular Profile of Subungual Melanoma: A MelaNostrum Consortium Study of 68 Cases Reporting BRAF, NRAS, KIT, and TERT Promoter Status
David Millan-Esteban, Zaida García-Casado, Anna Macià, et al.
Dermatology and Therapy
|
April 16, 2025
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
Clinical and Experimental Dermatology
|
April 16, 2025
A Long-Term Real-Life Safety Study of Guselkumab in Psoriasis Patients with Infectious Comorbidities, Malignancies or Heart Disease: The EARLY Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
Page
of 29
Search research articles
Search
Showing results (191-200 of 284) with videos related to
Sort By:
Page
of 29
Clinical, Cosmetic and Investigational Dermatology
|
April 10, 2023
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study
Marina Talamonti, Filomena Russo, Giovanna Malara, et al.
Dermatology and Therapy
|
January 23, 2025
Real-Life Experience with Tildrakizumab in Plaque Psoriasis with Palmoplantar Involvement: A Multi-Center Retrospective Italian Study
Federico Diotallevi, Maria Esposito, Maria Concetta Fargnoli, et al.
Dermatology Practical & Conceptual
|
March 30, 2026
A Risk-Scoring Classifier for the Diagnosis and Management of Atypical Melanocytic Lesions of the Palms: the iDScore_palmar Model
Linda Tognetti, Sofia Lo Conte, Chiara Miracapillo, et al.
Dermatology Practical & Conceptual
|
November 14, 2025
GRINCH Index: Measuring Patient Satisfaction During Christmas Holiday Gift Programs
Giulio Gualdi, Laura Bigi, Clara De Simone, et al.
Psoriasis (Auckland, N.Z.)
|
September 22, 2025
Long-Term Real-World Effectiveness and Drug Survival of Guselkumab in Patients with Psoriasis: A 5-Year Retrospective Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
Expert Opinion on Biological Therapy
|
June 16, 2022
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year
Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini, et al.
The Journal of Investigative Dermatology
|
July 30, 2013
Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families
Xueying Liang, Ruth M Pfeiffer, Wen-Qing Li, et al.
Dermatology (Basel, Switzerland)
|
November 2, 2023
Molecular Profile of Subungual Melanoma: A MelaNostrum Consortium Study of 68 Cases Reporting BRAF, NRAS, KIT, and TERT Promoter Status
David Millan-Esteban, Zaida García-Casado, Anna Macià, et al.
Dermatology and Therapy
|
April 16, 2025
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
Clinical and Experimental Dermatology
|
April 16, 2025
A Long-Term Real-Life Safety Study of Guselkumab in Psoriasis Patients with Infectious Comorbidities, Malignancies or Heart Disease: The EARLY Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
Page
of 29